Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2001 1
2002 1
2003 2
2004 1
2010 1
2012 1
2015 1
2018 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
[What rheumatologists can learn from ophthalmologists].
Becker MD, Max R, Dimitriou A, Saurenmann T, Lorenz HM, Jansen A, Lortz S, Grulich-Henn J, Weber M. Becker MD, et al. Among authors: saurenmann t. Z Rheumatol. 2018 Aug;77(6):469-476. doi: 10.1007/s00393-018-0489-3. Z Rheumatol. 2018. PMID: 29881952 Review. German.
Disease evolution in systemic juvenile idiopathic arthritis: an international, observational cohort study through JIRcohort.
Wallimann M, Bouayed K, Cannizzaro E, Kaiser D, Belot A, Merlin E, Poignant S, Wouters C, Hofer F, Saurenmann T, Koryllou A, Carlomagno R, Mejbri M, Hofer M, Theodoropoulou K. Wallimann M, et al. Among authors: saurenmann t. Pediatr Rheumatol Online J. 2023 Sep 7;21(1):96. doi: 10.1186/s12969-023-00886-9. Pediatr Rheumatol Online J. 2023. PMID: 37679749 Free PMC article.
Epidemiology of childhood arthritis in Switzerland.
Hofer M, Saurenmann T, Bolz D, Sauvain MJ. Hofer M, et al. Among authors: saurenmann t. Soz Praventivmed. 2001;46(5):285-7. doi: 10.1007/BF01321078. Soz Praventivmed. 2001. PMID: 11759334 No abstract available.
Phagocyte-specific S100 proteins and high-sensitivity C reactive protein as biomarkers for a risk-adapted treatment to maintain remission in juvenile idiopathic arthritis: a comparative study.
Gerss J, Roth J, Holzinger D, Ruperto N, Wittkowski H, Frosch M, Wulffraat N, Wedderburn L, Stanevicha V, Mihaylova D, Harjacek M, Len C, Toppino C, Masi M, Minden K, Saurenmann T, Uziel Y, Vesely R, Apaz MT, Kuester RM, Elorduy MJ, Burgos-Vargas R, Ioseliani M, Magni-Manzoni S, Unsal E, Anton J, Balogh Z, Hagelberg S, Mazur-Zielinska H, Tauber T, Martini A, Foell D; Paediatric Rheumatology International Trials Organization (PRINTO). Gerss J, et al. Among authors: saurenmann t. Ann Rheum Dis. 2012 Dec;71(12):1991-7. doi: 10.1136/annrheumdis-2012-201329. Epub 2012 Jun 11. Ann Rheum Dis. 2012. PMID: 22689317 Clinical Trial.
11 results